Clinical Trials Browser

INDUSTRY × Neurofibroma, Plexiform × 30 days × Clear all

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT07407803 2026-04-06

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

Phase 3 Recruiting

177 enrolled

CNS

Neurofibroma, Plexiform

NCT03975829 2026-04-02

Pediatric Long-Term Follow-up and Rollover Study

Phase 4 Active not recruiting

163 enrolled

CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT06360406 2026-03-31

Real-World Treatment Study of Koselugo (Selumetinib)

Recruiting

200 enrolled

CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT05028166 2026-03-27

Individual Patient Compassionate Use of Mirdametinib

Available

CNS

Neurofibromatoses, Neurofibroma, Plexiform

NCT04924608 2026-03-23

KOMET

Phase 3 Active not recruiting

145 enrolled 17 charts 3 FDA

CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

NCT06541847 2026-03-20

INSPIRE-NF1

Phase 2 Recruiting

25 enrolled

CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Clinical Trials

ReNeu

Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas

Pediatric Long-Term Follow-up and Rollover Study

Real-World Treatment Study of Koselugo (Selumetinib)

Individual Patient Compassionate Use of Mirdametinib

KOMET

INSPIRE-NF1